Literature DB >> 27335334

Structure-Driven Pharmacology of Transient Receptor Potential Channel Vanilloid 1.

Ignacio Díaz-Franulic1, Javier Caceres-Molina2, Romina V Sepulveda2, Fernando Gonzalez-Nilo2, Ramon Latorre1.   

Abstract

The transient receptor potential vanilloid 1 (TRPV1) ion channel is a polymodal receptor that mediates the flux of cations across the membrane in response to several stimuli, including heat, voltage, and ligands. The best known agonist of TRPV1 channels is capsaicin, the pungent component of "hot" chili peppers. In addition, peptides found in the venom of poisonous animals, along with the lipids phosphatidylinositol 4,5-biphosphate, lysophosphatidic acid, and cholesterol, bind to TRPV1 with high affinity to modulate channel gating. Here, we discuss the functional evidence regarding ligand-dependent activation of TRPV1 channels in light of structural data recently obtained by cryoelectron microscopy. This review focuses on the mechanistic insights into ligand binding and allosteric gating of TRPV1 channels and the relevance of accurate polymodal receptor biophysical characterization for drug design in novel pain therapies.
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27335334     DOI: 10.1124/mol.116.104430

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Ratio of Hydrophobic-Hydrophilic and Positive-Negative Residues at Lipid-Water-Interface Influences Surface Expression and Channel Gating of TRPV1.

Authors:  Somdatta Saha; Sushama Mohanta; Rashmita Das; Ritesh Dalai; Nikhil Tiwari; Ankit Tiwari; Abhishek Kumar; Chandan Goswami
Journal:  J Membr Biol       Date:  2022-05-24       Impact factor: 1.843

Review 2.  Venom Peptide Toxins Targeting the Outer Pore Region of Transient Receptor Potential Vanilloid 1 in Pain: Implications for Analgesic Drug Development.

Authors:  Sung-Min Hwang; Youn-Yi Jo; Cinder Faith Cohen; Yong-Ho Kim; Temugin Berta; Chul-Kyu Park
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

Review 3.  Organellar TRP channels.

Authors:  Xiaoli Zhang; Meiqin Hu; Yexin Yang; Haoxing Xu
Journal:  Nat Struct Mol Biol       Date:  2018-10-29       Impact factor: 15.369

4.  TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds' pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development.

Authors:  A Garami; E Pakai; H A McDonald; R M Reilly; A Gomtsyan; J J Corrigan; E Pinter; D X D Zhu; S G Lehto; N R Gavva; P R Kym; A A Romanovsky
Journal:  Acta Physiol (Oxf)       Date:  2018-02-16       Impact factor: 6.311

5.  Myrcene and terpene regulation of TRPV1.

Authors:  C Jansen; L M N Shimoda; J K Kawakami; L Ang; A J Bacani; J D Baker; C Badowski; M Speck; A J Stokes; A L Small-Howard; H Turner
Journal:  Channels (Austin)       Date:  2019-12       Impact factor: 2.581

6.  Nerve growth factor in muscle afferent neurons of peripheral artery disease and autonomic function.

Authors:  Lu Qin; Jianhua Li
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

Review 7.  TRPV1: A Target for Rational Drug Design.

Authors:  Vincenzo Carnevale; Tibor Rohacs
Journal:  Pharmaceuticals (Basel)       Date:  2016-08-23

8.  TRPV1 Inhibits the Ventilatory Response to Hypoxia in Adult Rats, but Not the CO₂-Drive to Breathe.

Authors:  Luis Gustavo A Patrone; Jaime B Duarte; Kênia Cardoso Bícego; Alexandre A Steiner; Andrej A Romanovsky; Luciane H Gargaglioni
Journal:  Pharmaceuticals (Basel)       Date:  2019-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.